.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Merck
Mallinckrodt
US Army
Colorcon
Queensland Health
Daiichi Sankyo
Deloitte
Citi
AstraZeneca

Generated: December 13, 2017

DrugPatentWatch Database Preview

ESTAZOLAM Drug Profile

« Back to Dashboard

When do Estazolam patents expire, and what generic alternatives are available?

Estazolam is a drug marketed by Mayne Pharma, Par Pharm, and Watson Labs. and is included in three NDAs.

The generic ingredient in ESTAZOLAM is estazolam. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the estazolam profile page.
Drug patent expirations by year for ESTAZOLAM

Pharmacology for ESTAZOLAM

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

Medical Subject Heading (MeSH) Categories for ESTAZOLAM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mayne PharmaESTAZOLAMestazolamTABLET;ORAL074921-001Jul 10, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmESTAZOLAMestazolamTABLET;ORAL074826-002Jul 3, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mayne PharmaESTAZOLAMestazolamTABLET;ORAL074921-002Jul 10, 1997ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmESTAZOLAMestazolamTABLET;ORAL074826-001Jul 3, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsESTAZOLAMestazolamTABLET;ORAL074818-002Aug 19, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsESTAZOLAMestazolamTABLET;ORAL074818-001Aug 19, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
US Army
McKinsey
Colorcon
Novartis
Chinese Patent Office
Merck
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot